Cardinal health launches next generation medical device to improve neonatal feeding

The ntrainer™ system 2.0 is the only fda class ii biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding.  dublin, ohio , aug. 30, 2023 /prnewswire/ -- cardinal health (nyse: cah) announced today the launch of its next generation ntrainer™ system 2.0, a medical device designed to help premature and newborn infants develop the oral coordination skills important for the transition to independent feeding faster, thus helping to reduce their neonatal intensive care unit (nicu) length of stay.
CAH Ratings Summary
CAH Quant Ranking